Monitoring After Cardiac Arrest: Electroencephalogram and Cerebral Oximetry in Predicting Outcome
Key facts
- Who runs it
- Haseki Training and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 44 people enrolled
- Started
- 15 Jun 2024
- Ended
- 1 Jan 2025
- Type of study
- Observational
- Record updated
- 19 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- experienced cardiac arrest
- permanent spontaneous circulation is maintained for at least 48 hours after CPR
- immediate intensive care follow-up after cardiac resuscitation
Who cannot take part
- • Patients under 18 years of age; Presence of previously known neurological disease (cerebral palsy, neurodegenerative disease, encephalitis, etc.); Immunosuppressive patients due to previously known hematological malignancy or solid tumor; Patients with a history of head trauma; Patients with cardiac arrest within 48 hours after spontaneous circulation is established; Patients sedated for more than 24 hours
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Because of its high incidence, it is essential to determine the neurological prognosis after cardiac arrest. However, there is not much information to guide post-cardiac arrest care. Also, dynamic monitoring of the state of the brain can help provide information about the patient's prognosis other than previously described serum biomarkers. Therefore, the researchers will monitor postcardiac arrest patients in the intensive care unit for 48 hours by electroencephalogram and cerebral oximetry and collect blood samples for serum biomarkers: neuron-specific enolase (NSE), human neurogranin (NRGN) and human trigger receptor expressed on myeloid cells (TREM-2), which are associated with neuronal damage. And investigate the relation of these data to mortality.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of Survival Outcomes After Cardiac Arrest by Monitoring Electroencephalogram, Cerebral Oximetry and Serum Biomarkers
- Record updated
- 19 March 2025